ELV Elevance Health, Inc. stock chart & analysis
Conviction 58HealthcareScan · Fri, Nov 6, 2026Elevance Health, Inc. (ELV) closed at $425.62 (-1.48%) on Nov 6, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 53, RS Rating 88, -5.6% from its 52-week high, +21.4% year to date. Sector: Healthcare · Hospital & Medical Service Plans.
Financials as of Wed, Sep 30, 2026 · quarterly.
ELV technical analysis
Trend
ELV is in an uptrend: price is above the 50-day, which is above the 200-day moving average. It closed 3.1% above the 50-day ($412.87) and 13.9% above the 200-day ($373.62). ADX(14) at 20 points to a weak trend — more range than direction. It meets 8 of 8 trend-template criteria.
Momentum
RSI(14) is 53, in the bullish half of its range. MACD crossed below its signal line 7 sessions ago. Its RS Rating of 88 puts its weighted 12-month performance ahead of about 88% of the US market.
Volume and volatility
Volume on the latest session ran 1.0× its 20-day average. It trades about $645.4M a day on average. ATR(14) is $13.27, 3.1% of price — its typical daily range. Chaikin Money Flow (-0.11) shows distribution.
Key levels
The chart pattern's support is $391.32 and its resistance $442.35. The 52-week range is $274.84 to $450.69; price is 5.6% below the high and 54.9% above the low. The VWAP anchored at the 52-week high is $428.23, above price.
Performance
ELV returned +1.3% (1 week), +6.2% (1 month), +7.0% (3 months), +12.6% (6 months), +33.8% (1 year), +21.4% (year to date).
About Elevance Health, Inc.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
Hospital & Medical Service Plans · Listed 2001 · 97,100 employees
Congress activity
Disclosed STOCK Act trades in ELV · 10 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Alan Armstrong senate · R · OK · traded 2026-03-27 | Buy | $1K–$15K | 2026-03-27 | 2026-07-21 | |
 Markwayne Mullin senate · traded 2025-12-29 | Buy | $15K–$50K | 2025-12-29 | 2026-01-16 | |
 Gilbert Cisneros house · D · CA · traded 2025-08-05 | Buy | $1K–$15K | 2025-08-05 | 2025-09-12 | |
 Valerie Hoyle house · D · OR · traded 2024-10-29 | Buy | $1K–$15K | 2024-10-29 | 2025-09-12 | |
Valerie Hoyle house · D · OR · traded 2025-01-13 | Sell | $1K–$15K | 2025-01-13 | 2025-09-12 | |
 Lisa McClain house · R · MI · traded 2025-08-13 | Sell | $1K–$15K | 2025-08-13 | 2025-09-12 | |
Lisa McClain house · R · MI · traded 2025-06-24 | Buy | $1K–$15K | 2025-06-24 | 2025-08-13 | |
Lisa McClain house · R · MI · traded 2025-07-10 | Buy | $1K–$15K | 2025-07-10 | 2025-08-13 | |
 Jefferson Shreve house · R · IN · traded 2025-05-12 | Sell | $15K–$50K | 2025-05-12 | 2025-06-22 | |
Gilbert Cisneros house · D · CA · traded 2025-05-30 | Sell | $1K–$15K | 2025-05-30 | 2025-06-06 |
Insider activity
SEC Form 4 transactions in ELV · open-market 3 buys · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
LAVU RATNAKAR EVP & Chief Digital Info Ofr · Common Stock · 2026-11-05 | Sell | 1.3K | $572K | 2026-11-05 | 2026-11-06 |
BOUDREAUX GAIL President and CEO · Common Stock · 2026-07-17 | Buy | 680 | $249K | 2026-07-17 | 2026-07-17 |
BOUDREAUX GAIL President and CEO · Common Stock · 2026-07-17 | Buy | 2.04K | $753K | 2026-07-17 | 2026-07-17 |
PERU RAMIRO G Director · Common Stock · 2026-07-17 | Buy | 1K | $366K | 2026-07-17 | 2026-07-17 |
Penczek Ronald W CAO & Controller · Employee Stock Option (Right to Buy) · 2026-05-19 | Exercise | 877 | $0 | 2026-05-19 | 2026-05-20 |
Penczek Ronald W CAO & Controller · Employee Stock Option (Right to Buy) · 2026-05-19 | Exercise | 654 | $0 | 2026-05-19 | 2026-05-20 |
Penczek Ronald W CAO & Controller · Common Stock · 2026-05-19 | Exercise | 654 | $177K | 2026-05-19 | 2026-05-20 |
Penczek Ronald W CAO & Controller · Common Stock · 2026-05-19 | Sell | 1.53K | $617K | 2026-05-19 | 2026-05-20 |
Penczek Ronald W CAO & Controller · Common Stock · 2026-05-19 | Exercise | 877 | $273K | 2026-05-19 | 2026-05-20 |
SCHULMAN AMY W Director · Common Stock · 2026-05-13 | Grant | 563 | $0 | 2026-05-13 | 2026-05-15 |
SEC filings
EDGAR filings in ELV · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.